Oncology Today with Dr Neil Love artwork

Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

Oncology Today with Dr Neil Love

English - May 20, 2024 18:00 - 1 hour - 52.7 MB
Medicine Health & Fitness Science dr neil love research to practice oncology today oncology cme Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
Next Episode: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayLocHER2PosBC24).

Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities.

CME information and select publications here.